Severe caffeine poisoning treated with intermittent hemodialysis under circulatory support. 2024

Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
Emergency and Critical Care Center, Yamanashi Prefectural Central Hospital, 1-1-1, Fujimi, Kofu City, Yamanashi 400-0027, Japan. Electronic address: sincostan5432@yahoo.co.jp.

Caffeine poisoning can cause fatal ventricular arrhythmias. In this report, we describe a case of severe caffeine poisoning with extraordinarily high blood caffeine levels. Despite developing refractory ventricular fibrillation, the patient was successfully treated with intermittent hemodialysis (IHD) under circulatory support by venoarterial extracorporeal membrane oxygenation (VA-ECMO). A 22-year-old male was transported to our hospital approximately 2.5 h after ingesting 200 highly caffeinated tablets (200 mg/tablet) (40 g caffeine total) in a suicide attempt. On arrival, the patient vomited frequently with a Glasgow Coma Scale score E3V2M5, heart rate 185 beats/min, and a blood pressure of 97/62 mmHg. Shortly after arrival, the patient developed ventricular fibrillation which was refractory either to three electrical defibrillations or antiarrhythmic drugs, resulting in endotracheal intubation for mechanical ventilation and VA-ECMO. Starting from 2 h after arrival, intermittent hemodialysis (IHD) was performed for 11 h, which markedly improved clinical symptoms and circulatory parameters. Serum caffeine level was 454.9 mg/dL upon arrival at the hospital, but it decreased to 55.5 mg/dL by the end of IHD treatment. Renal replacement therapy (RRT) including intermittent hemodiafiltration, continuous hemodiafiltration, and IHD was continued because of rhabdomyolysis with myoglobinuria and secondary caused acute kidney injury. The patient was weaned off VA-ECMO on hospital day 7, extubated on hospital day 18, weaned from RRT on hospital day 46, and was transferred to another hospital for physical rehabilitation on hospital day 113. IHD under circulatory support by VA-ECMO should be considered in severe caffeine poisoning causing potentially fatal arrhythmias.

UI MeSH Term Description Entries
D008297 Male Males
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D014693 Ventricular Fibrillation A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST. Fibrillation, Ventricular,Fibrillations, Ventricular,Ventricular Fibrillations
D015199 Extracorporeal Membrane Oxygenation Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of SMOKE INHALATION INJURY; RESPIRATORY FAILURE; and CARDIAC FAILURE. ECMO Extracorporeal Membrane Oxygenation,Oxygenation, Extracorporeal Membrane,Venoarterial ECMO,Venoarterial Extracorporeal Membrane Oxygenation,Venovenous ECMO,Venovenous Extracorporeal Membrane Oxygenation,ECLS Treatment,ECMO Treatment,Extracorporeal Life Support,ECLS Treatments,ECMO Treatments,ECMO, Venoarterial,ECMO, Venovenous,Extracorporeal Life Supports,Extracorporeal Membrane Oxygenations,Life Support, Extracorporeal,Membrane Oxygenation, Extracorporeal,Treatment, ECLS,Treatment, ECMO,Venoarterial ECMOs,Venovenous ECMOs
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
August 2022, The American journal of emergency medicine,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
January 2018, Case reports in critical care,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
January 2021, Kidney medicine,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
January 1989, Journal de toxicologie clinique et experimentale,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
April 2018, Nephrologie & therapeutique,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
February 2015, Revue medicale suisse,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
May 2024, The American journal of emergency medicine,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
April 2018, Der Anaesthesist,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
January 2023, Seminars in dialysis,
Daichi Mitsui, and Yoshito Kamijo, and Takumi Yoshino, and Tomoki Hanazawa, and Tomohiro Yoshizawa, and Fumiaki Iwase
August 2021, The American journal of emergency medicine,
Copied contents to your clipboard!